Mitogen-activated-protein kinase (MAP kinase) cascades are effector mechanisms for many growth factor signals implicated in developmental processes, including appendage outgrowth and organogenesis. The cascade culminates in extracellular-signal-regulated MAP kinase (ERK), which enters the nucleus. ERK activity reflects the competing actions of upstream activator kinases and inhibitory MAP kinase phosphatases. We have studied embryonic expression of the dual-specificity MAP kinase phosphatase PYST1/MKP3, which is a specific and potent regulator of the ERK class of MAP kinases. We found dynamic patterns of mPyst1 messenger RNA in important signalling centres associated with cell proliferation and patterning in developing mouse embryos, including presegmental paraxial mesoderm, limb bud and branchial arch mesenchyme, midbrain/hindbrain isthmus, and nasal, dental, hair, and mammary placodes. Most of these have been characterised as sites of FGF/FGFR signalling. q
Results
Sequential tissue interactions are fundamental to early morphogenesis and organogenesis stages of embryonic development. Many of these interactions involve paracrine signalling through transmembrane receptors of the tyrosine kinase (RTK) type, such as fibroblast growth factor receptors (FGFRs). Signal transduction through RTKs involves the mitogen-activated-protein (MAP) kinase pathway, culminating in the movement of extracellular signal-regulated MAP kinase (ERK) into the nucleus, and ultimately to transcriptional change. The developmental outcome of this pathway, in terms of cell proliferation and differentiation, depends on both the competence of the cell in terms of available transcription factors, and on the amount of active ERK that enters the nucleus. This in turn depends on the competing influences of MAP kinase activators and inhibitors.
PYST1/MKP3 is a specific and potent inhibitory regulator of the ERK class of MAP kinases; its specificity is dependent on the formation of a tight physical complex between the phosphatase and its ERK substrate, leading to catalytic activation (Groom et al., 1996; Muda et al., 1996; Camps et al., 1998) . In order to investigate the possibility that PYST1 is actively involved in developmental function of FGF/FGFR signalling, we have investigated the expression of mPyst1 in mouse embryos from embryonic day (E) 7.5 to E14.5. We show that its spatiotemporal pattern of transcription is consistent with a role in modulation of FGF-FGFR signalling, particularly with respect to FGF8 function.
1.1. Expression from E8.5 to E10.5
Pyst1 expression in E7.5 mouse embryos is localised to the primitive streak and emerging primary mesenchyme, and to the extra-embryonic tissues (Fig. 1A) , in a domain coinciding with that of Fgf8 (Crossley and Martin, 1995) . In E8.5 embryos it is concentrated in two well-defined domains within the head (Fig. 1B, C) . Neuroepithelial expression is localised at the midbrain/hindbrain boundary (future isthmus), a known site of FGF8-regulated patterning (Crossley et al., 1996) , and at the adjacent lateral edge of the neural plate (Fig. 1C) . A discrete domain lateral to prorhombomere B of the hindbrain (Fig. 1C, arrowhead) was revealed by sections (not shown) to be mesenchymal. In the caudal region, expression is in recently formed presegmental paraxial mesoderm and in the primitive streak, consistent with the E7.5 expression (Fig. 1D, E) ; there is also a low level of expression in the recently formed neural epithelium (Fig. 1E) . The presegmental mesodermal domain of Pyst1 seen at E8.5 strongly resembles that of Fgf8 in chick embryos of equivalent stages (Dubrulle et al., 2001) . Expression of Pyst1 is still evident in the midbrain-hindbrain isthmus following neural tube closure at E9.0 (Fig.  1F) . Transcripts are detectable in nasal placodes (Fig. 1F , inset), in the mandibular primordium and other branchial arches (arrowheads), and in the lateral plate mesoderm at the level of the nascent forelimb bud.
By E9.5, Pyst1 is expressed in different regions of the brain: midbrain-hindbrain isthmus, telencephalon-diencephalon boundary, and in the medial wall of the cerebral hemispheres ( Fig. 2A) . Expression is detected in the fourth ventricle roof (Fig. 2B ). Strong expression is evident from the earliest stages in limb mesenchyme (Fig. 2C, D) . Somitic expression of Pyst1 (Fig. 2C, D) is up-regulated in a craniocaudal sequence. By E10.5, expression of Pyst1 in facial mesenchyme is in both medial and lateral nasal processes and in the oral surface of mandibular and maxillary mesenchyme ( Fig. 2D-F) . Transcripts are detected in cells of Rathke's pouch and in the medial walls of the cerebral hemispheres (Fig. 2E, F) . The level of expression in pharyngeal arches is increased and more localised than at E9.0 ( Fig. 2D-F) . Expression in presomitic mesoderm and neural epithelium continues throughout E9.5-E10.5, including the tailbud, a known site of Fgf8 expression (Gofflot et al., 1997 ; Fig. 2C, G) . There is transient expression in the most recently formed somite pair prior to the longer-term expression; down-regulation is seen at the most cranial levels (Fig. 2C, D) . E10.5 fore-and hind-limbs express Pyst1 strongly in distal mesenchyme underlying apical ectodermal ridge, but transcripts are not detected in the apical ectodermal ridge or other regions of limb ectoderm (Fig.  2H, I ). , lateral nasal, and medial nasal processes and Rathke's pouch, and in the telencephalon either side of the midline (asterisk); (F) coronal section showing the mainly mesenchymal location of the facial expression domains, although some expression is also seen in adjacent epithelium in each site, as well as in the medial walls of the cerebral hemispheres; (G) expression in trunk somites, limbs, and tailbud; (H) forelimb expression is concentrated in distal mesoderm but absent from apical ectodermal ridge; (I) section through limb along plane indicated in (H), confirming absence of Pyst1 expression in all ectoderm, including the ridge (arrowhead). ch, cerebral hemisphere; fb, forebrain; fl, forelimb; hb, hindbrain; hl, hindlimb; is, isthmus; lnp, lateral nasal process; mb, midbrain; md, mandibular process; mnp, medial nasal process; mx, maxillary process; n, nasal pit; rp, Rathke's pouch; tb, tailbud; tl, telencephalon. Scale bars: (A,D) 250 mm; (B,G-I) 100 mm; (C-F) 200 mm.
Expression at E11.0 and E11.5
Expression of Pyst1 continues as previously in the central nervous system and facial processes (Fig. 3A, B) ; proximal first/second arch expression appears to be located to the developing middle ear region (Fig. 3A, arrowhead) . Expression in Rathke's pouch is reduced (Fig. 2B) . Limb expression becomes confined to a narrow rim of distal mesenchyme (Fig. 2C, D) . Expression continues in the (reduced) tailbud (Fig. 2C) ; in tail somites, expression divides into epaxial and hypaxial components of the myotome (Fig. 2E) . Between the limbs, punctate domains of Pyst1 expression are found in the five bilaterally paired mammary gland primordia (Fig. 2F ).
Expression from E12.5 to E14.5
During this period, Pyst1 expression becomes highly localised to developing digits, skin appendages, and oral structures (Fig. 4) . At E12.5, as the limb plate changes shape and future digits become evident in the forelimbs, Pyst1 expression begins to be down-regulated in interdigital regions (Fig. 4A) ; by E13.5, signal is confined to the digit tips, continuing here during E14.0-E14.5 as the digits grow in length (Fig. 4B, C, F) . Expression of Pyst1 is visible in the tail somites, although expression in the tailbud is lost as axial extension nears completion (Fig. 4A, B) . Robust but transient Pyst1 expression is detected in hair placodes (Fig.  4B, G) , expression being localised to the hypoderm (Fig.   4H ). Whisker placodes express Pyst1 sequentially during E14.0-E14.5, commencing in the most proximal follicle in each row, progressing to more distal follicles, and then being down-regulated in proximal follicles (Fig. 4F) . Pyst1 transcripts are also detected in the nares (Fig. 4F ) and external pinna of the ear (Fig. 4I) . Pyst1 is expressed in dental lamina at E13.5 (Fig. 4D, E) , and in incisor and molar precursors at E14.5 (Fig. 4J) . Expression is seen in lateral and medial regions of the developing tongue at E13.5 (Fig.  4E, arrowheads) , the palatal shelves at both E13.5 and E14.5 (Fig. 4D, J) , and salivary glands at E14.5 (Fig. 4K, L) .
These observations reveal that Pyst1 is dynamically expressed in many developmental sites in which FGF-FGFR signalling has previously been reported.
Methods
Murine Pyst1 EST AA793427 was identified by BLAST searches of dbEST using sequences of human PYST1 and rat MKP3. IMAGE Consortium clone #989755 was obtained from the Human Genome Mapping Project resource centre (HGMP-RC, Hinxton, Cambridge, UK). Sequence analysis revealed unique XbaI and PstI sites, which were used to subclone a 680-bp coding-region fragment into pBluescript. Digoxigenin-labelled probe synthesis and in situ hybridisation with a range of mouse embryos were performed according to Wilkinson (1992) . Frozen sections were prepared for photomicrography according to Stern (1993) .
